Search Results | Showing 81 - 90 of 120 results for "Biotech" |
| | | ... the healthcare sector over the last few years, people have taken it as a safe haven," Ms Cox said. Pharmaceutical and biotech company CSL Ltd was up 45 cents at $35.35 by 1210 AEST. At 1213 AEST, the price of spot gold in Sydney was $US1485.78, up $US9.98 ... |
| | | | The Australian stock market was more than half a per cent higher at noon as speculation re-emerged that Shell could sell its stake in Woodside to BHP. At 1200 AEDT, the benchmark S&P/ASX200 index was 28.4 points higher, or 0.59 per cent, at 4,866.3 ... |
| | | | The Australian market is receiving clear, positive leads from offshore trading overnight, with all three key Wall Street indices substantially higher, as were European and Asian markets. Gold was flat but higher, oil was higher, but silver and copper ... |
| | | | ... The class action, held in the Federal Court of Australia, alleges that Bell Potter encouraged clients to buy shares in biotech company, Progen Pharmaceuticals (PGL) in 2007. Shortly after, Bell Potter was appointed as co-underwriter of a capital raising ... |
| | | | ... separate charges after allegedly raising funds from nine investors through Financial Partners, Venture Capital Management and Biotech Solutions before allegedly depositing the money into bank accounts he controlled, using the funds for the three companies ... |
| | | | ... Treasury notes. In company news, WPG Resources Ltd executive chairman Bob Duffin will address a Sydney Mining Club luncheon. Biotech company Broadvector Ltd is scheduled to list on the Australian Stock Exchange. On Wednesday, Australian stocks touched ... |
| | | | Singapore sovereign wealth fund (SWF), Temasek Holdings, has invested $50 million in Californian-based renewable chemicals and fuel start-up company, Amyris Biotechnologies. The company will use the funds to support commercial plant design and construction ... |
| | | | ... they have underpins their valuation." Rather, the investment team is targeting companies that attract business from Asia. Biotech stocks remain a focus. "We see biotech companies as the engine for these big pharmaceuticals firms so we've kept them even ... |
| | | | International equities manager Wingate Asset Management has appointed former Royal Bank of Scotland executive Alastair MacLeod as senior investment analyst. MacLeod joins Wingate from Royal Bank of Scotland in New York where he held roles including ... |
| | | | Victorian Funds Management Corporation (VFMC), ARIA and Meat Industry Employees' Superannuation Fund are investing in the GBS Venture Partners BioVentures IV fund, which closed with more than $100 million in commitments. Macquarie Group, Quay Partners ... |
|